Revenue
$87.2m
+2.0% ↑ vs $85.4m
PBT grew 14.9% on 2.0% revenue growth, but a $28.5m inventory build cut operating cash flow from $4.5m to $0.0m and turned free cash flow negative.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY23 vs HY22
Revenue
$87.2m
+2.0% ↑ vs $85.4m
EBITDA
—
— vs $26.4m
Net profit after tax
$16m
-15.3% ↓ vs $18.9m
Net cash inflow from operating activities
$0.02m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Operating profit
$22.9m
+19.9% ↑ vs $19.1m
Profit before tax
$22.4m
+14.9% ↑ vs $19.5m
Cash and cash equivalents
$25.7m
+29.2% ↑ vs $19.9m
Total assets
$218.4m
+23.1% ↑ vs $177.4m
What changed
Revenue rose 2.0% to $87.2m and PBT advanced 14.9% to $22.4m, but reported NPAT fell 15.3% to $16.0m because the effective tax rate normalised from 2.7% to 28.5%. Capex more than doubled to $9.4m, lifting capex intensity to 10.8% of revenue from 4.7%, which turned free cash flow pre-lease to -$9.4m from +$0.5m. Despite the cash drain in the half, gross borrowings fell to $7.3m from $16.3m and cash rose to $25.7m, leaving Rakon in a stronger net cash position than a year ago.
What matters
OCF/EBITDA fell from 17.1% to 0.1% as inventory absorbed nearly the entire operating result. Free cash flow to NPAT swung to -58.7%, so a 14.9% PBT advance has produced no cash. This matters because the underlying business looks healthier on the income statement than the cash flow can yet validate, and the working-capital cycle, not trading, is now the binding constraint.
Tax normalisation, not operating weakness, explains the NPAT fall. PBT grew 14.9% while NPAT fell 15.3% — a 30.2pp gap driven entirely by the effective tax rate moving from 2.7% to 28.5%. The cleaner operating read is PBT growth. Treating the headline NPAT decline as evidence of business deterioration would misread the period.
Capex is stepping up alongside inventory. Capex more than doubled to $9.4m, against an FY22 first-half base of $4.0m. Combined with the inventory build, Rakon is committing balance sheet ahead of revenue. That is a bet on the demand outlook holding; if second-half volumes do not lift, the cash position absorbs further pressure.
Expectations
The supplied shape context shows HY22 represented 49.7% of FY22 revenue, so the first half is roughly balanced on revenue, while NPAT was first-half weighted at 57.2% of FY22. Annualised current revenue of $174.3m is broadly in line with FY22's $172.0m, so the run-rate is flat even as PBT growth is stronger.
The inventory and capex stance implies management expects a second-half volume lift. The release does not quantify forward orders, so the gap between that internal assumption and external visibility is the central uncertainty for the result.
Quality of result
The balance sheet has also strengthened, with gross borrowings more than halving and net cash deepening.
The less durable elements are more pointed. The NPAT comparison is corrupted by the tax-rate reset, so any headline earnings narrative overstates prior-year underlying performance. Operating cash flow of $0.017m provides no support for the PBT growth, and the inventory and capex build together produced a $9.4m free cash outflow. ROE fell from 14.8% to 12.3%, reflecting both the higher tax rate and a larger equity base. Underlying EBITDA growth of 6% is partly attributed to foreign exchange gains in the commentary, so the operating-only contribution is smaller than the headline implies.
Unresolved
This briefing cannot assess Rakon's forward order visibility or the likely timing of inventory conversion to cash, as no forward-work disclosure is supplied.
Chat
Ask follow-up questions about Rakon's HY23 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Rakon 1H23 Financial Results & Business Update - Presentation
HY23 / results presentationRakon 1H23 Interim Report
HY23 / financial reportRakon 1H23 Results Announcement
HY23 / results announcementRakon 1H23 Results Announcement Commentary
HY23 / results releaseRakon 1H22 Interim Report
HY22 / financial reportRakon 1H22 Results Announcement
HY22 / results announcementRakon 1H22 Results Announcement
HY22 / results releaseRakon Annual Report 2022
FY22 / financial reportRakon FY22 Results Announcement
FY22 / results announcementRakon FY22 Results Announcement
FY22 / results releaseRakon 1H23 Results Business Update Webcast & Teleconference
HY23 / commentaryRAKON FY23 EARNINGS GUIDANCE
HY23 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Cash conversion quality
This result converted 0.1% of EBITDA to operating cash flow, -17.0pp versus the prior comparable period.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 30.2pp, with a distortion flag in the result.
Leverage and balance-sheet risk
Net debt / EBITDA is -0.66x, -0.52x versus the prior comparable period.
ROE and capital efficiency
ROE was 12.3%, -2.5pp versus the prior comparable period.
Get the next Rakon briefing and related NZX reporting-season updates by email.